ENDOXAN Side Effects

6784709-0 | Appendicitis
on Jun 11, 2010 Female patient from JAPAN , 42 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Endoxan (View Usage). Patient experienced the following unwanted or unexpected effects: appendicitis (What is appendicitis?). Endoxan dosage: . During the same period patient was treated with ADRIACIN (View Adriacin Review and Adriacin Label ).

6640589-5 | Acute Myeloid Leukaemia
Patient was taking Endoxan (View Usage). Patient had the following side effects: acute myeloid leukaemia on Mar 12, 2010 from GERMANY Additional patient health information: Female patient , 59 years of age, was diagnosed with breast cancer (What is breast cancer?), leukopenia and. Endoxan dosage: Taken On 20aug2007. During the same period patient was treated with TAXOL (Initiated On 06jul2007 And Given Until 06-aug-2007) (View Taxol Review and Taxol Label ), EPIRUBICIN (Taken On 24may2007) (View Epirubicin Review and Epirubicin Label ), NEULASTA (Started On 07jun07) (View Neulasta Review and Neulasta Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DARBEPOETIN ALFA (View Darbepoetin Alfa Review and Darbepoetin Alfa Label ). Patient was hospitalized.

6543199-3 | Blood Pressure Decreased, Bradycardia, Coma, Confusional State
Adverse event was reported on Jan 15, 2010 by a Male patient taking Endoxan (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: FRANCE , 57 years of age, After Endoxan was administered, patient had the following side effects: blood pressure decreased, bradycardia, coma, confusional state. During the same period patient was treated with MANTADIX (View Mantadix Review and Mantadix Label ), DANTRIUM (View Dantrium Review and Dantrium Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ). Patient was hospitalized.

6397433-3 | Cytolytic Hepatitis
on Oct 05, 2009 Female patient from FRANCE , 62 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Endoxan (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis. Endoxan dosage: . During the same period patient was treated with EFFERALGAN (View Efferalgan Review and Efferalgan Label ), BI PROFENID (View Bi-profenid Review and Bi-profenid Label ), FLUOROURACIL (1df=50mg/ml) (View Fluorouracil Review and Fluorouracil Label ), FARMORUBICINE (View Farmorubicine Review and Farmorubicine Label ), ABUFENE (View Abufene Review and Abufene Label ), LYRICA (View Lyrica Review and Lyrica Label ), MONOCRIXO (View Monocrixo Review and Monocrixo Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.


6299048-4 | Cardiogenic Shock, Cor Pulmonale Acute, Pulmonary Embolism
on Jul 31, 2009 Female patient from JAPAN , 59 years of age, was diagnosed with ovarian neoplasm and was treated with Endoxan (View Usage). Patient had the following side effects: cardiogenic shock, cor pulmonale acute, pulmonary embolism (What is pulmonary embolism?). Endoxan dosage: . During the same period patient was treated with BLEOMYCIN SULFATE (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), STAGID (View Stagid Review and Stagid Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), PRIMPERAN (View Primperan Review and Primperan Label ), DIFFU K (View Diffu-k Review and Diffu-k Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6299026-5 | Bone Marrow Failure, Mucosal Inflammation, Palmar-plantar Erythrodysaesthesia Syndrome, Staphylococcal Infection
Patient was taking Endoxan (View Usage). After Endoxan was administered, patient had the following side effects: bone marrow failure, mucosal inflammation, palmar-plantar erythrodysaesthesia syndrome, staphylococcal infection (What is staphylococcal infection?) on Jul 31, 2009 from JAPAN Additional patient health information: Female patient , 26 years of age, was diagnosed with t-cell lymphoma and. Endoxan dosage: 26dec08,3rd, 09jan09. Day 1 Total Dose-10mg.. During the same period patient was treated with BLEOMYCIN SULFATE (26dec08,13jan09.day1and 5 Total Dose=10mg.) (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), ADRIBLASTINE (26dec08, 09jan09.) (View Adriblastine Review and Adriblastine Label ), ELDISINE (Day1-total Dose=10mg Day5-total Dose=10mg;13jan09.) (View Eldisine Review and Eldisine Label ), SOLU MEDROL (Day1 Total Dose=10mg, Day2=15mg,day5=10mg. 26dec08,13jan09.) (View Solu-medrol Review and Solu-medrol Label ), METHOTREXATE SODIUM (Day2=15mg. Roa=my) (View Methotrexate Sodium Review and Methotrexate Sodium Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), ALGINIC ACID (View Alginic Acid Review and Alginic Acid Label ). Patient was hospitalized.

6245873-5 | Cardiogenic Shock, Cor Pulmonale Acute, Pulmonary Embolism
Adverse event was reported on Jun 23, 2009 by a Female patient taking Endoxan (View Usage) (Dosage: ) was diagnosed with ovarian neoplasm and. Location: JAPAN , 59 years of age, Patient experienced the following unwanted or unexpected effects: cardiogenic shock, cor pulmonale acute, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with BLEOMYCIN SULFATE (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), STAGID (View Stagid Review and Stagid Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), PRIMPERAN (View Primperan Review and Primperan Label ), DIFFU K (View Diffu-k Review and Diffu-k Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6112543-3 | Bone Marrow Failure, Mucosal Inflammation, Palmar-plantar Erythrodysaesthesia Syndrome, Staphylococcal Infection
on Mar 10, 2009 Female patient from JAPAN , 26 years of age, was diagnosed with t-cell lymphoma and was treated with Endoxan (View Usage). Patient had the following side effects: bone marrow failure, mucosal inflammation, palmar-plantar erythrodysaesthesia syndrome, staphylococcal infection (What is staphylococcal infection?). Endoxan dosage: 26dec08,3rd, 09jan09. Day 1 Total Dose-10mg.. During the same period patient was treated with BLEOMYCIN SULFATE (26dec08,13jan09.day1and 5 Total Dose=10mg.) (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), ADRIBLASTINE (26dec08, 09jan09.) (View Adriblastine Review and Adriblastine Label ), ELDISINE (Day1-total Dose=10mg Day5-total Dose=10mg;13jan09.) (View Eldisine Review and Eldisine Label ), SOLU MEDROL (Day1 Total Dose=10mg, Day2=15mg,day5=10mg. 26dec08,13jan09.) (View Solu-medrol Review and Solu-medrol Label ), METHOTREXATE SODIUM (Day2=15mg. Roa=my) (View Methotrexate Sodium Review and Methotrexate Sodium Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ), ALGINIC ACID (View Alginic Acid Review and Alginic Acid Label ). Patient was hospitalized.

5925644-7 | Bone Marrow Failure, Interstitial Lung Disease, Renal Impairment
on Oct 10, 2008 Male patient from JAPAN , 66 years of age, was diagnosed with interstitial lung disease, off label use, pneumonia (What is pneumonia?), hypertension, analgesia and was treated with Endoxan (View Usage). After Endoxan was administered, patient had the following side effects: bone marrow failure, interstitial lung disease, renal impairment. Endoxan dosage: . During the same period patient was treated with COTRIM (Dose Not Specified; Formulation = Tablet) (View Cotrim Review and Cotrim Label ), RENIVACE (View Renivace Review and Renivace Label ), MEROPEN (View Meropen Review and Meropen Label ), PASIL (View Pasil Review and Pasil Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

5914759-5 | Cardiac Tamponade, Hepatic Function Abnormal, Pericardial Effusion, Renal Impairment
Patient was taking Endoxan (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac tamponade, hepatic function abnormal, pericardial effusion, renal impairment on Sep 29, 2008 from UNITED STATES Additional patient health information: Male patient , 60 years of age, was diagnosed with central nervous system lymphoma and. Endoxan dosage: . During the same period patient was treated with UROMITEXAN (Also Taken Orally 2000mg, Every Day On 27-jun-2008) (View Uromitexan Review and Uromitexan Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

5914021-0 | Cerebral Thrombosis
Adverse event was reported on Sep 30, 2008 by a Male patient taking Endoxan (View Usage) (Dosage: ) was diagnosed with t-cell type acute leukaemia and. Location: UNITED STATES , 56 years of age, Patient had the following side effects: cerebral thrombosis. During the same period patient was treated with METHOTREXATE SODIUM (Duration - 2 Admin.15mg On 19aug08,12mg On 03sep08.) (View Methotrexate Sodium Review and Methotrexate Sodium Label ), ARACYTINE (View Aracytine Review and Aracytine Label ), DEPO MEDROL (View Depo-medrol Review and Depo-medrol Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), ONCOVIN (View Oncovin Review and Oncovin Label ). Patient was hospitalized.

5911881-4 | Renal Disorder
on Sep 28, 2008 Female patient from UNITED STATES , 66 years of age, was diagnosed with interstitial lung disease, off label use, pneumonia (What is pneumonia?) and was treated with Endoxan (View Usage). After Endoxan was administered, patient had the following side effects: renal disorder. Endoxan dosage: . During the same period patient was treated with MEROPEN (View Meropen Review and Meropen Label ), PASIL (View Pasil Review and Pasil Label ). Patient was hospitalized.

5908321-8 | Acute Myeloid Leukaemia
on Sep 25, 2008 Female patient from UNITED STATES , 67 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Endoxan (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia. Endoxan dosage: . During the same period patient was treated with EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

5904397-2 | Bladder Cancer
Patient was taking Endoxan (View Usage). Patient had the following side effects: bladder cancer (What is bladder cancer?) on Sep 08, 2008 from UNITED STATES Additional patient health information: Male patient , 61 years of age, was diagnosed with mycosis fungoides and. Endoxan dosage: 347 G Over A 6 Year, 7 Month Period.

5900203-0 | Cytolytic Hepatitis, Dyspnoea, Febrile Bone Marrow Aplasia, Hypernatraemia, Hypertension, Paralysis, Renal Failure, Stevens-johnson Syndrome
Adverse event was reported on Sep 17, 2008 by a Male patient taking Endoxan (View Usage) (Dosage: ) was diagnosed with acute lymphocytic leukaemia and. Location: UNITED STATES , 14 years of age, weighting 143.3 lb, After Endoxan was administered, patient had the following side effects: cytolytic hepatitis, dyspnoea, febrile bone marrow aplasia, hypernatraemia, hypertension, paralysis (What is paralysis?), renal failure, stevens-johnson syndrome. During the same period patient was treated with GLEEVEC (Resumed On 18aug08.) (View Gleevec Review and Gleevec Label ), METHOTREXATE (Resumed On 18aug08.) (View Methotrexate Review and Methotrexate Label ), VINCRISTINE (Also Given On 14-may-2008.) (View Vincristine Review and Vincristine Label ), ARACYTINE (View Aracytine Review and Aracytine Label ), BACTRIM (Resumed On 18aug08.) (View Bactrim Review and Bactrim Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), MESNA (View Mesna Review and Mesna Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

5900201-7 | Cardiac Failure, Cardiomyopathy, Lymphoma, Pleural Haemorrhage, Pneumonia
on Sep 19, 2008 Female patient from SPAIN , 75 years of age, was treated with Endoxan (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, cardiomyopathy (What is cardiomyopathy?), lymphoma (What is lymphoma?), pleural haemorrhage, pneumonia (What is pneumonia?). Endoxan dosage: . During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), SODIUM CHLORIDE 0.9% (View Sodium Chloride 0.9% Review and Sodium Chloride 0.9% Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ).

5898856-9 | Cardiac Arrest, Interstitial Lung Disease, Respiratory Arrest
on Aug 18, 2008 Male patient from UNITED STATES , child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with Endoxan (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), interstitial lung disease, respiratory arrest. Endoxan dosage: . Patient was hospitalized.

5897746-5 | Confusional State, Hyponatraemia, Vomiting
Patient was taking Endoxan (View Usage). After Endoxan was administered, patient had the following side effects: confusional state, hyponatraemia, vomiting on Sep 16, 2008 from UNITED STATES Additional patient health information: Male patient , 52 years of age, was diagnosed with primary progressive multiple sclerosis, depression (What is depression?) and. Endoxan dosage: . During the same period patient was treated with FLUOXETINE HCL (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ), URBANYL (View Urbanyl Review and Urbanyl Label ), NEXIUM (View Nexium Review and Nexium Label ), MOTILIUM (View Motilium Review and Motilium Label ), UROMITEXAN (View Uromitexan Review and Uromitexan Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

5897475-8 | Aphasia, Confusional State, Hyponatraemia
Adverse event was reported on Sep 16, 2008 by a Female patient taking Endoxan (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 58 years of age, Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), confusional state, hyponatraemia. During the same period patient was treated with LYRICA (1 Df: 150mgx2tabs) (View Lyrica Review and Lyrica Label ), LIORESAL (1 Df:10mgx3tabs) (View Lioresal Review and Lioresal Label ), IXPRIM (View Ixprim Review and Ixprim Label ), UROMITEXAN (View Uromitexan Review and Uromitexan Label ). Patient was hospitalized.

5891674-7 | Condition Aggravated, Depression
on Sep 11, 2008 Female patient from UNITED STATES , 36 years of age, was diagnosed with polyarteritis nodosa and was treated with Endoxan (View Usage). Patient had the following side effects: condition aggravated, depression (What is depression?). Endoxan dosage: 1 Df: 1 Dose (units Not Specified). During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ), DIFFU K (View Diffu-k Review and Diffu-k Label ), ACTONEL (View Actonel Review and Actonel Label ), PLAVIX (View Plavix Review and Plavix Label ), MOPRAL (View Mopral Review and Mopral Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ). Patient was hospitalized.

5884665-3 | Cardiac Failure, Liver Disorder, Multi-organ Failure, Renal Failure
on Sep 07, 2008 Female patient from UNITED STATES , 62 years of age, was diagnosed with breast cancer stage i and was treated with Endoxan (View Usage). After Endoxan was administered, patient had the following side effects: cardiac failure, liver disorder, multi-organ failure, renal failure. Endoxan dosage: . During the same period patient was treated with FARMORUBICIN (View Farmorubicin Review and Farmorubicin Label ), FEMARA (View Femara Review and Femara Label ).

5878995-9 | Anaphylactic Shock, Bradycardia, Pericardial Effusion
Patient was taking Endoxan (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, bradycardia, pericardial effusion on Sep 03, 2008 from UNITED STATES Additional patient health information: Male patient , child 9 years of age, was diagnosed with lymphoma (What is lymphoma?), prophylaxis of nausea and vomiting and. Endoxan dosage: Received Over A One-hour Period From 10:07 A.m. To 11:17 A.m.. During the same period patient was treated with KYTRIL (View Kytril Review and Kytril Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), DAUNOMYCIN (36mg Over A One Hour Period.) (View Daunomycin Review and Daunomycin Label ), PREDONINE (View Predonine Review and Predonine Label ).

5876425-4 | Acute Myeloid Leukaemia, Acute Respiratory Distress Syndrome, Febrile Bone Marrow Aplasia, Left Ventricular Failure, Sepsis, Stomatitis
Adverse event was reported on Sep 01, 2008 by a Female patient taking Endoxan (View Usage) (Dosage: ) was diagnosed with burkitt's lymphoma, acute lymphocytic leukaemia and. Location: UNITED STATES , 58 years of age, Patient had the following side effects: acute myeloid leukaemia, acute respiratory distress syndrome, febrile bone marrow aplasia, left ventricular failure, sepsis (What is sepsis?), stomatitis. During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5876416-3 | Bladder Cancer
on Aug 27, 2008 Male patient from UNITED STATES , 61 years of age, was diagnosed with mycosis fungoides and was treated with Endoxan (View Usage). After Endoxan was administered, patient had the following side effects: bladder cancer (What is bladder cancer?). Endoxan dosage: .

5876413-8 | Bladder Cancer
on Aug 28, 2008 Male patient from UNITED STATES , 29 years of age, was diagnosed with nephrotic syndrome and was treated with Endoxan (View Usage). Patient experienced the following unwanted or unexpected effects: bladder cancer (What is bladder cancer?). Endoxan dosage: .

5871767-0 | Bladder Cancer
Patient was taking Endoxan (View Usage). Patient had the following side effects: bladder cancer (What is bladder cancer?) on Aug 27, 2008 from UNITED STATES Additional patient health information: Male patient , 61 years of age, was diagnosed with mycosis fungoides and. Endoxan dosage: .

5856644-3 | Acute Myeloid Leukaemia
Adverse event was reported on Aug 22, 2008 by a Female patient taking Endoxan (View Usage) (Dosage: Taken On 20aug2007) was diagnosed with breast cancer (What is breast cancer?), leukopenia and. Location: GERMANY , 59 years of age, After Endoxan was administered, patient had the following side effects: acute myeloid leukaemia. During the same period patient was treated with TAXOL (Taken On 06jul2007) (View Taxol Review and Taxol Label ), EPIRUBICIN (Taken On 24may2007) (View Epirubicin Review and Epirubicin Label ), NEULASTA (Started On 07jun07) (View Neulasta Review and Neulasta Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), DARBEPOETIN ALFA (View Darbepoetin Alfa Review and Darbepoetin Alfa Label ). Patient was hospitalized.

5851482-X | Sigmoiditis
on Aug 11, 2008 Female patient from UNITED STATES , 56 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), insomnia and was treated with Endoxan (View Usage). Patient experienced the following unwanted or unexpected effects: sigmoiditis. Endoxan dosage: . During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), MOPRAL (Mopral 20) (View Mopral Review and Mopral Label ), ACTONEL (Actonel 35) (View Actonel Review and Actonel Label ), PROPOXYPHENE HCL AND ACETAMINOPHEN (View Propoxyphene Hcl And Acetaminophen Review and Propoxyphene Hcl And Acetaminophen Label ), CACIT D3 (View Cacit D3 Review and Cacit D3 Label ), STILNOX (View Stilnox Review and Stilnox Label ). Patient was hospitalized.

5844997-1 | Nephrogenic Anaemia, Renal Impairment
on Aug 06, 2008 Female patient from JAPAN , 88 years of age, was diagnosed with lymphoma (What is lymphoma?) and was treated with Endoxan (View Usage). Patient had the following side effects: nephrogenic anaemia, renal impairment. Endoxan dosage: . During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ).

5842901-3 | Atrial Fibrillation, Blood Creatinine Increased, Fall, Hyperkalaemia, Hyponatraemia, Malaise, Palpitations, Renal Impairment, Vision Blurred
Patient was taking Endoxan (View Usage). After Endoxan was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), blood creatinine increased, fall (What is fall?), hyperkalaemia, hyponatraemia, malaise, palpitations, renal impairment, vision blurred on Aug 04, 2008 from UNITED STATES Additional patient health information: Female patient , 83 years of age, . Endoxan dosage: . During the same period patient was treated with ATACAND (From 16mg,daily; Reduced To 4mg/day,po) (View Atacand Review and Atacand Label ), AMLOR (View Amlor Review and Amlor Label ), DETENSIEL (View Detensiel Review and Detensiel Label ), ASPEGIC 325 (View Aspegic 325 Review and Aspegic 325 Label ), ELISOR (View Elisor Review and Elisor Label ), UN ALFA (View Un-alfa Review and Un-alfa Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), ZOMETA (View Zometa Review and Zometa Label ). Patient was hospitalized.

5839745-5 | Lung Disorder, Pyrexia, Sepsis
Adverse event was reported on Jul 29, 2008 by a Female patient taking Endoxan (View Usage) (Dosage: 1cyc:20feb08 2cyc:27feb08 3cyc:20mar08 4cyc:28mar08 Ther Dur:5wk) was diagnosed with high grade b-cell lymphoma burkitt-like lymphoma stage iv and. Location: UNITED STATES , 60 years of age, Patient experienced the following unwanted or unexpected effects: lung disorder, pyrexia, sepsis (What is sepsis?). During the same period patient was treated with VINCRISTINE SULFATE (1cyc:20feb08 2cyc:27feb08 3cyc:20mar08 4cyc:28mar08 Ther Dur: 5wk) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DOXORUBICIN HCL (1cyc:27feb08 2cyc:28mar08 Ther Dur: 1month) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), MABTHERA (1cyc:27feb08 2cyc:20mar08 3cyc:28mar08 Ther Dur: 1month) (View Mabthera Review and Mabthera Label ), ARACYTINE (1cyc:27feb08 2cyc:28mar08 Ther Dur: 1 Month) (View Aracytine Review and Aracytine Label ), DEPO MEDROL (1cyc:27feb08 2cyc:28mar08 Ther Dur: 1 Month) (View Depo-medrol Review and Depo-medrol Label ), SEROPRAM (View Seropram Review and Seropram Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), ANTIHYPERTENSIVE (View Antihypertensive Review and Antihypertensive Label ). Patient was hospitalized.

5832522-0 | Acute Pulmonary Oedema, Agranulocytosis, Anaemia, Colitis Ulcerative, Thrombocytopenia
on Jul 25, 2008 Female patient from UNITED STATES , 26 years of age, was diagnosed with brain neoplasm and was treated with Endoxan (View Usage). Patient had the following side effects: acute pulmonary oedema, agranulocytosis, anaemia, colitis ulcerative, thrombocytopenia. Endoxan dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), OFLOCET (View Oflocet Review and Oflocet Label ), UROMITEXAN (View Uromitexan Review and Uromitexan Label ), SOLUPRED (Stopped On Day 3) (View Solupred Review and Solupred Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), ZOPHREN (View Zophren Review and Zophren Label ). Patient was hospitalized.

5825072-9 | Guillain-barre Syndrome, Multi-organ Failure, Neoplasm Progression, Pancytopenia, Pseudomonal Sepsis
on Jul 25, 2008 Female patient from UNITED STATES , 71 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Endoxan (View Usage). After Endoxan was administered, patient had the following side effects: guillain-barre syndrome (What is guillain-barre syndrome?), multi-organ failure, neoplasm progression, pancytopenia, pseudomonal sepsis. Endoxan dosage: Also Received On 11-jun-2007 3gm Via Intravenous Once. During the same period patient was treated with ETOPOPHOS PRESERVATIVE FREE (View Etopophos Preservative Free Review and Etopophos Preservative Free Label ), VELCADE (View Velcade Review and Velcade Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

5825060-2 | Acute Myeloid Leukaemia
Patient was taking Endoxan (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia on Jul 25, 2008 from GERMANY Additional patient health information: Female patient , 59 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Endoxan dosage: Taken On Aug 2007. During the same period patient was treated with TAXOL (Taken On Jul2007) (View Taxol Review and Taxol Label ), EPIRUBICIN (Taken On May2007) (View Epirubicin Review and Epirubicin Label ). Patient was hospitalized.

5824068-0 | Altered State Of Consciousness, Binocular Eye Movement Disorder, Ileus Paralytic, Inappropriate Antidiuretic Hormone Secretion, Speech Disorder
Adverse event was reported on Jul 18, 2008 by a Female patient taking Endoxan (View Usage) (Dosage: Dose-940 Mg From 29may08-29may08 And 940 Mg From 09jun-19jun08) was diagnosed with acute lymphocytic leukaemia, cystitis haemorrhagic and. Location: JAPAN , child 5 years of age, Patient had the following side effects: altered state of consciousness, binocular eye movement disorder, ileus paralytic, inappropriate antidiuretic hormone secretion, speech disorder. During the same period patient was treated with ONCOVIN (View Oncovin Review and Oncovin Label ), SOLITA T NO. 3 (View Solita-t No. 3 Review and Solita-t No. 3 Label ), PREDONINE (View Predonine Review and Predonine Label ), COTRIM (View Cotrim Review and Cotrim Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), PANTHENOL (View Panthenol Review and Panthenol Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ). Patient was hospitalized.

5824051-5 | Breast Cancer
on Jul 18, 2008 Female patient from UNITED STATES , 24 years of age, was diagnosed with bone sarcoma and was treated with Endoxan (View Usage). After Endoxan was administered, patient had the following side effects: breast cancer (What is breast cancer?). Endoxan dosage: . During the same period patient was treated with VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), DACTINOMYCIN (View Dactinomycin Review and Dactinomycin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

5822659-4 | Progressive Multifocal Leukoencephalopathy
on Jul 16, 2008 Female patient from UNITED STATES , 55 years of age, was diagnosed with diffuse large b-cell lymphoma, dermatomyositis and was treated with Endoxan (View Usage). Patient experienced the following unwanted or unexpected effects: progressive multifocal leukoencephalopathy. Endoxan dosage: . During the same period patient was treated with PREDONINE (Received 8 Courses.) (View Predonine Review and Predonine Label ), PIRARUBICIN (View Pirarubicin Review and Pirarubicin Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ).

5814381-5 | Oropharyngeal Pain, Pancytopenia
Patient was taking Endoxan (View Usage). Patient had the following side effects: oropharyngeal pain, pancytopenia on Jul 10, 2008 from JAPAN Additional patient health information: Female patient , 56 years of age, was diagnosed with breast cancer (What is breast cancer?), infection prophylaxis and. Endoxan dosage: . During the same period patient was treated with EPIRUBICIN HCL (View Epirubicin Hcl Review and Epirubicin Hcl Label ), PL (View Pl Review and Pl Label ), ZOFRAN (View Zofran Review and Zofran Label ), DEXAMETHASONE SODIUM PHOSPHATE (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label ), CRAVIT (View Cravit Review and Cravit Label ), ISODINE (View Isodine Review and Isodine Label ), MEIACT (View Meiact Review and Meiact Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

5813326-1 | Altered State Of Consciousness, Binocular Eye Movement Disorder, Inappropriate Antidiuretic Hormone Secretion, Speech Disorder
Adverse event was reported on Jul 06, 2008 by a Female patient taking Endoxan (View Usage) (Dosage: ) was diagnosed with acute lymphocytic leukaemia and. Location: UNITED STATES , child 5 years of age, After Endoxan was administered, patient had the following side effects: altered state of consciousness, binocular eye movement disorder, inappropriate antidiuretic hormone secretion, speech disorder. During the same period patient was treated with ONCOVIN (View Oncovin Review and Oncovin Label ), PREDONINE (View Predonine Review and Predonine Label ), BAKTAR (View Baktar Review and Baktar Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), PANTHENOL (View Panthenol Review and Panthenol Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ). Patient was hospitalized.

5806860-1 | Agranulocytosis, Anaemia, Chills, Confusional State, Eyelid Ptosis, Leukopenia, Livedo Reticularis, Lymphopenia, Motor Dysfunction
on Jun 30, 2008 Female patient from UNITED STATES , 85 years of age, was diagnosed with temporal arteritis, infection (What is infection?) and was treated with Endoxan (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, anaemia, chills, confusional state, eyelid ptosis, leukopenia, livedo reticularis, lymphopenia, motor dysfunction. Endoxan dosage: 1df=0.5g/m2 Cycle 1 1st Course On 10-apr-08,cycle 2 On 02-may-08 And Cycle 3 On 09-jun-08. During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), CLAFORAN (View Claforan Review and Claforan Label ), OFLOCET (View Oflocet Review and Oflocet Label ), BACTRIM (View Bactrim Review and Bactrim Label ), FLAGYL (View Flagyl Review and Flagyl Label ), UROMITEXAN (View Uromitexan Review and Uromitexan Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ). Patient was hospitalized.

5804672-6 | Agranulocytosis, Blood Pressure Decreased, Chills, Dehydration, Diarrhoea, Haemoglobin Decreased, Infection, Neutropenia, Oral Pain
on Jul 01, 2008 Male patient from UNITED STATES , 77 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Endoxan (View Usage). Patient had the following side effects: agranulocytosis, blood pressure decreased, chills, dehydration, diarrhoea, haemoglobin decreased, infection (What is infection?), neutropenia, oral pain. Endoxan dosage: First Cycle In Dec07, Second Cycle Given On 09jan08. During the same period patient was treated with DOXORUBICIN HCL (First Cycle In Dec07, Second Cycle Given On 09jan08.) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), ONCOVIN (First Cycle In Dec07, Second Cycle Given On 09jan08) (View Oncovin Review and Oncovin Label ), MABTHERA (First Cycle In Dec07, Second Cycle Given On 09jan08) (View Mabthera Review and Mabthera Label ), CORTANCYL (First Cycle In Dec07, Second Cycle Given On 09jan08, Stopped On 14jan2008.) (View Cortancyl Review and Cortancyl Label ), TAHOR (View Tahor Review and Tahor Label ), VASTAREL (View Vastarel Review and Vastarel Label ), LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (View Losartan Potassium And Hydrochlorothiazide Review and Losartan Potassium And Hydrochlorothiazide Label ), COSOPT (View Cosopt Review and Cosopt Label ). Patient was hospitalized.

5801095-0 | Hypogammaglobulinaemia
Patient was taking Endoxan (View Usage). After Endoxan was administered, patient had the following side effects: hypogammaglobulinaemia on Jun 25, 2008 from UNITED STATES Additional patient health information: Male patient , 50 years of age, was diagnosed with systemic lupus erythematosus and. Endoxan dosage: .

5800597-0 | Epistaxis, Malignant Neoplasm Progression, Small Intestinal Perforation
Adverse event was reported on Jun 25, 2008 by a Male patient taking Endoxan (View Usage) (Dosage: ) was diagnosed with lymphoma (What is lymphoma?) and. Location: UNITED STATES , 76 years of age, Patient experienced the following unwanted or unexpected effects: epistaxis, malignant neoplasm progression, small intestinal perforation. During the same period patient was treated with PREDONINE (1 Dosage Form = 70 Unk Units) (View Predonine Review and Predonine Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ).

5799438-X | Acute Pulmonary Oedema, Agranulocytosis, Colitis Ulcerative
on Jun 24, 2008 Female patient from UNITED STATES , 26 years of age, was diagnosed with brain neoplasm and was treated with Endoxan (View Usage). Patient had the following side effects: acute pulmonary oedema, agranulocytosis, colitis ulcerative. Endoxan dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), OFLOCET (View Oflocet Review and Oflocet Label ), UROMITEXAN (View Uromitexan Review and Uromitexan Label ), SOLUPRED (Stopped On Day 3) (View Solupred Review and Solupred Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), ZOPHREN (View Zophren Review and Zophren Label ). Patient was hospitalized.

5798799-5 | Acute Coronary Syndrome, Anaemia, Leukopenia
on Jun 24, 2008 Male patient from UNITED STATES , 81 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Endoxan (View Usage). After Endoxan was administered, patient had the following side effects: acute coronary syndrome, anaemia, leukopenia. Endoxan dosage: . During the same period patient was treated with VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), MABTHERA (View Mabthera Review and Mabthera Label ), INSULATARD (View Insulatard Review and Insulatard Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DETENSIEL (View Detensiel Review and Detensiel Label ). Patient was hospitalized.

5798649-7 | Chromosome Analysis Abnormal, Cytogenetic Abnormality, Disease Progression, Myelodysplastic Syndrome, Venoocclusive Liver Disease
Patient was taking Endoxan (View Usage). Patient experienced the following unwanted or unexpected effects: chromosome analysis abnormal, cytogenetic abnormality, disease progression, myelodysplastic syndrome, venoocclusive liver disease on Jul 01, 2008 from JAPAN Additional patient health information: Female patient , child 9 years of age, was diagnosed with desmoplastic small round cell tumour and. Endoxan dosage: . During the same period patient was treated with BRIPLATIN (View Briplatin Review and Briplatin Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PIRARUBICIN HCL (View Pirarubicin Hcl Review and Pirarubicin Hcl Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), ONCOVIN (View Oncovin Review and Oncovin Label ).

5798647-3 | Agranulocytosis, Chills, Diarrhoea, Neutropenia, Oral Pain, Pyrexia, Renal Failure, Vomiting
Adverse event was reported on Jun 24, 2008 by a Male patient taking Endoxan (View Usage) (Dosage: First Cycle In Dec07, Second Cycle Given On 09jan08) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED STATES , 77 years of age, Patient had the following side effects: agranulocytosis, chills, diarrhoea, neutropenia, oral pain, pyrexia, renal failure, vomiting. During the same period patient was treated with DOXORUBICIN HCL (First Cycle In Dec07, Second Cycle Given On 09jan08.) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), ONCOVIN (First Cycle In Dec07, Second Cycle Given On 09jan08) (View Oncovin Review and Oncovin Label ), MABTHERA (First Cycle In Dec07, Second Cycle Given On 09jan08) (View Mabthera Review and Mabthera Label ), CORTANCYL (First Cycle In Dec07, Second Cycle Given On 09jan08, Stopped On 14jan2008.) (View Cortancyl Review and Cortancyl Label ), TAHOR (View Tahor Review and Tahor Label ), VASTAREL (View Vastarel Review and Vastarel Label ), LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (View Losartan Potassium And Hydrochlorothiazide Review and Losartan Potassium And Hydrochlorothiazide Label ), COSOPT (View Cosopt Review and Cosopt Label ). Patient was hospitalized.

5787991-1 | Herpes Zoster, Neuralgia
on Jun 17, 2008 Female patient from UNITED STATES , 27 years of age, was diagnosed with systemic lupus erythematosus and was treated with Endoxan (View Usage). After Endoxan was administered, patient had the following side effects: herpes zoster, neuralgia. Endoxan dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), RITUXIMAB (Taken On Day 6, 12, 19.) (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

5787088-0 | Leukaemia, Myelodysplastic Syndrome, Venoocclusive Liver Disease
on Jun 19, 2008 Female patient from JAPAN , child 9 years of age, was diagnosed with desmoplastic small round cell tumour and was treated with Endoxan (View Usage). Patient experienced the following unwanted or unexpected effects: leukaemia, myelodysplastic syndrome, venoocclusive liver disease. Endoxan dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PIRARUBICIN HCL (View Pirarubicin Hcl Review and Pirarubicin Hcl Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ).

5782927-1 | Mucoepidermoid Carcinoma
Patient was taking Endoxan (View Usage). Patient had the following side effects: mucoepidermoid carcinoma on Jun 19, 2008 from UNITED STATES Additional patient health information: Female patient , 24 years of age, was diagnosed with t-cell type acute leukaemia, leukaemia recurrent prophylaxis and. Endoxan dosage: . During the same period patient was treated with VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), PIRARUBICIN HCL (View Pirarubicin Hcl Review and Pirarubicin Hcl Label ), L ASPARAGINASE (View L-asparaginase Review and L-asparaginase Label ).